Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Empagliflozin Tablets bulk supplier for pharma manufacturers

Empagliflozin Tablets 10 mg, 25 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10 mg, 25 mg

Reference Brands: Jardiance(EU & US)

Category: Diabetes

Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in kidneys, promoting urinary glucose excretion. This lowers blood sugar in type 2 diabetes. Benefits include improved glycemic control, weight loss, blood pressure reduction, and cardiovascular risk reduction, with a low risk of hypoglycemia.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Empagliflozin Tablets? List it or send an offer →

Product Description:

Empagliflozin is a selective SGLT2 inhibitor approved for managing type 2 diabetes mellitus, heart failure, and chronic kidney disease. In the USA, the FDA approved Jardiance (10 mg, 25 mg) in 2014. In the EU, it is authorized by the EMA under centralized procedure. It is often prescribed as monotherapy or in combination with metformin or insulin. Empagliflozin improves glycemic control and reduces cardiovascular risks. Regular renal monitoring is advised. Pharmatradz.com connects global buyers and suppliers with licensed manufacturers of Empagliflozin, ensuring regulatory-compliant sourcing for B2B needs in both regulated and semi-regulated markets.

Also known as: empagliflozina (Spanish, Portuguese), empagliflozine (French), Empagliflozin (German), эмпаглифлозин (Russian), أمباغليفلوزين (Arabic), 恩格列净 (Chinese), エンパグリフロジン (Japanese), 엠파글리플로진 (Korean).

Empagliflozin Tablets — third party manufacturing & bulk supply

Empagliflozin Tablets 10 mg, 25 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Empagliflozin Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Empagliflozin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Empagliflozin Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Empagliflozin is used to manage Type 2 diabetes mellitus. It helps lower blood sugar levels, reduce cardiovascular risk in patients with diabetes and heart disease, and support weight reduction.

Empagliflozin is a synthetic small-molecule drug and an SGLT2 (sodium-glucose co-transporter 2) inhibitor, which blocks glucose reabsorption in the kidneys, promoting its excretion through urine.

The main trade name is Jardiance.

Empagliflozin is manufactured by Boehringer Ingelheim in collaboration with Eli Lilly.

The generic name is Empagliflozin.

The brand name is Jardiance.

Empagliflozin is manufactured in Europe and the USA and distributed globally, including the USA, EU, India, and Japan.

La empagliflozina es un inhibidor del cotransportador SGLT2 indicado, junto con dieta y ejercicio, para el control glucémico en la diabetes tipo 2, y también para el tratamiento de la insuficiencia cardíaca y de la enfermedad renal crónica. Es un medicamento de prescripción y se usa bajo supervisión médica. PharmaTradz pone en contacto a importadores, distribuidores y hospitales con licencia con fabricantes certificados GMP.

A empagliflozina é um inibidor do SGLT2 indicado, junto com dieta e exercícios, para o controle glicêmico no diabetes tipo 2, e também para o tratamento da insuficiência cardíaca e da doença renal crônica. É um medicamento de prescrição, usado com supervisão médica. Pela PharmaTradz, importadores, distribuidores e hospitais licenciados chegam a fabricantes com certificação GMP.

L’empagliflozine est un inhibiteur du SGLT2 indiqué, en complément d’un régime alimentaire et d’une activité physique, pour le contrôle glycémique du diabète de type 2, ainsi que dans le traitement de l’insuffisance cardiaque et de la maladie rénale chronique. Elle est délivrée sur ordonnance et utilisée sous surveillance médicale. PharmaTradz relie importateurs, distributeurs et hôpitaux agréés à des fabricants certifiés GMP.

Related Products

Dapagliflozin 10 mg Tablets

Strength:
10 mg

Form: Tablets

Reference Brands: Forxiga(US & EU)

View Details
Canagliflozin Tablets

Strength:
100 mg and 300 mg

Form: Tablets

Reference Brands: Invokana(US & EU)

View Details
Teneligliptin Tablets

Strength:
20 mg, 40mg

Form: Tablets

Reference Brands: Tenelia® (Japan/ Asia)

View Details
Liraglutide Subcutaneous Injection

Strength:
6 mg/mL solution

Form: Subcutaneous injection/Pre filled Pen

Reference Brands: Victoza(US & EU)

View Details
Alogliptin Tablet

Strength:
6.25 mg, 12.5 mg, 25 mg

Form: Tablet

Reference Brands: Nesina (USA/EU), Kazano (USA), Vipidia (EU)

View Details
NPH Human Insulin (rDNA Origin)

Strength:
40U/ml, 100U/ml

Form: Injection

Reference Brands: Humulin N (USA), Novolin N (USA), Insulatard (EU/UK)

View Details
Alogliptin/Metformin

Strength:
12.5mg+500mg / 12.5mg+850mg / 12.5mg+1000mg

Form: Tablets

Reference Brands: Kazano (USA), Vipdomet (EU)

View Details
Alogliptin / Pioglitazone Tablet

Strength:
12.5 mg / 30 mg, 25 mg / 15 mg, 25 mg / 30 mg, 25 mg / 45 mg

Form: Tablets

Reference Brands: Oseni (USA), Incresync(EU)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us